Is Tilray (TLRY) Stock a Good Buy? According to Jefferies, Yes
What the Tilray and Aphria Merger Means for Investors
Aphria or OrganiGram? Which is a Better Stock for Investors?
Tilray and Aphria Merger Date Nears, Don’t Ignore the Arbitrage
Why Investors Should Choose APHA Over TLRY Before the Merger
Aphria Stock Looks Solid Long Term, Cannabis Sector Heats Up
Top Developments in the Cannabis Industry’s Early Years
In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.
Cannabis Products: Tilray Partners with AB InBev
On December 19, Tilray (TLRY) announced a “research partnership” with one of the largest alcoholic beverage companies—AB InBev.
What Citron Research Has to Say about Aphria
Last week was a brutal week for Aphria (APHA) (APHQF).
Eight Capital Cut Aphria’s Target Price
Aphria stock lost nearly 25% on December 5. The stock has lost 42% in the three trading days in December.
Law Firms Investigate Aphria for Potential Violations
Due to Aphria’s (APHA) (APHQF) broad sell-off, several investors lost their investments. The investments might not be recovered.
Aphria Continued to Fall despite the Company’s Defense
On December 4, Aphria issued a press release defending its acquisitions in Latin America. The company tried to boost investors’ confidence.
Why Did Aphria Stock Fall 30% in November?
Aphria (APHQF) stock declined nearly 30.6% in November. The stock closed at 10.5 Canadian dollars on November 30.
Aurora Advances in Czech Republic with Medical Cannabis Shipments
On November 27, Aurora Cannabis (ACB) (ACBFF) announced that it completed its first shipment to the Czech Republic.
Canopy Growth Completes EBBU Acquisition
Canopy Growth (WEED) (CGC) announced yesterday that it completed the previously announced acquisition of EBBU.
Most Cannabis Companies Expected to Report Losses for the Quarter
Aurora Cannabis is estimated to report a loss per share of 0.07 Canadian dollars, which would be lower than the profit per share of 0.01 Canadian dollars in the corresponding quarter in 2017.
Why Canopy Growth Partnered with The Brink’s Company
On November 8, Canopy Growth (CGC) (WEED) announced a multiyear partnership with The Brink’s Company (BCO).
Jeff Sessions’ Resignation Could Be Good News for Cannabis Stocks
On November 7, US Attorney General Jeff Sessions resigned from his position.
October Was Tough on Cannabis Stocks: What’s Ahead?
The Horizons Marijuana Life Sciences ETF (HMMJ) lost almost 24% in October alone, and the ETFMG Alternative Harvest ETF (MJ) also fell ~24%.
Analyzing the Cannabis Sector’s EV-to-EBITDA Multiple
The median EV-to-EBITDA multiple of the nine cannabis stocks as of October 23 stood at 34x, which declined from 44.6x as of October 9.
Canopy Growth Is Optimistic about Cannabis Market
Recreational cannabis sales began in Canada on October 17. Canada is only the second country after Uruguay to legalize cannabis.
Tobacco Companies and Their Newfound Interest in Cannabis
On October 10, Reuters reported that tobacco giant Altria is in discussions with Aphria (APHQF) about acquiring a stake in the company.
Canopy Growth Exporting Medical Cannabis for US Research
On October 9, Canopy Growth (CGC) (WEED) announced that it has completed a legal transfer of medical cannabis to the United States.
Cannabis Company Namaste Caught in Yet Another Controversy
On October 9, Namaste, a licensed cannabis producer in Canada, was caught in the middle of yet another controversy related to litigation against the company.
Aurora Cannabis Moves Closer to Uruguay and Colombia
Aurora Cannabis has moved closer to having a presence in Uruguay and Colombia. The company’s board approved the deal with ICC Labs.
Aphria Announces Developments in South American Markets
On September 27, Aphria (APHQF) announced developments in the South American market with the acquisition of LATAM Holdings.
A Look at Aphria’s Price Target in September
The overall consensus recommendation for Aphria is a “buy.”
Analysts Raise Price Target for Canopy Growth in September
Canopy Growth is one of the top cannabis stocks (MJ) in terms of market capitalization followed by Aurora Cannabis (ACB) (ACBFF) and Aphria (APHQF).
How Cannabis Companies Are Blanketing the Cannabis Market
Product differentiation appears to be the primary strategic direction for most cannabis players to blanket the market with several products.
Tilray’s Q2 2018 Results and Its Strategic Focus
Tilray’s (TLRY) average selling prices and sales volume improved YoY in the second quarter. The company sold 1,514 kilograms during the quarter.
How Analysts Rate Hydropothecary in August
Hydropothecary (HYYDF) has done much better than other cannabis producers (HMMJ) such as Cronos (CRON), Aphria (APHQF), and Aurora Cannabis (ACB) (ACBFF).
Aphria Reports Quarterly Loss, PI Financial Raises Price Target
Aphria (APH) (APHQF) reported its fiscal 4Q 2018 earnings on August 1. It more than doubled its sales but had a net quarterly loss.
SMG’s Margin Expectations Could Be Concerning
The Scotts Miracle-Gro Company (SMG) continues to face margin headwinds in the lawn and garden segment.
Aurora Cannabis Announces Partnership with Cosmetic Company
On July 11, Aurora Cannabis announced it had established an agreement with Evio Beauty Group to develop hemp-based and CBD-based cosmetic products.
What EV-to-EBITDA Multiples Say about the Cannabis Sector
The EV-to-EBITDA multiple for the cannabis sector increased slightly to 36.3x as of July 10 from 35.4x a month ago.
Which Cannabis Stocks Are above Peer Median Valuation Multiple?
As of July 10, Canopy Growth (WEED) (CGC) was trading at a forward enterprise-value-to-sales multiple of 23.7x.
How Cannabis Stocks Fared Last Week
The Horizons Marijuana Life Sciences ETF rose 1.7% between June 29 and July 6.
Why Product Landscape Design Matters for Cannabis Stocks
The popularity of various cannabis consumption methods could guide the product landscape design for cannabis companies.
Aphria Stock: Analyst Recommendations and Target Prices
As of July 4, the average consensus price target for Aphria stood at 23.91 Canadian dollars.
Why the Cannabis Sector Rallied Last Week
Last week’s impressive gains pushed some of the cannabis stocks into positive YTD returns territory.
What Investors Are Paying for Cannabis Sector’s Forward EBITDA
The enterprise-value-to-EBITDA multiple for Canadian-licensed producers moved sideways in the last two weeks.
Cannabis Sector Update for the Week Ended May 4
Last week was broadly positive for the cannabis sector. The ETF Horizons Marijuana Life Sciences (HMMJ) rose 2.4%.
The Cannabis Sector: Mergers, Acquisitions, and Price Upgrades
The cannabis sector remains hot for mergers and acquisitions as companies rush to capture a piece of the recreational cannabis market.
Cannabis Sector Closes Positively in the Week Ended April 13
Last week (ended April 13), overall market sentiment was positive, with the S&P 500 rising 2% and the TSX 30 gaining 44 basis points.
What Analysts Recommend for MedReleaf
As of March 22, the consensus analyst mean rating on MedReleaf was 1.6, which remained unchanged from the previous month.
March Analyst Ratings and Price Targets for Aphria
Aphria (APHQF) was among the worst performers this year with a loss of 34% YTD (year-to-date).
Digging into Aphria’s Cost of Production
In this part of the series, we’ll discuss how Aphria’s (APHQF) production costs have evolved in the last four quarters.
Why Alcaliber Makes Sense for Canopy Growth
On March 6, Bloomberg Markets reported that Canopy Growth (WEED) put in a bid for privately held Spanish company Alcaliber.
How MedReleaf’s Capacity Expansion Plans Compare to Its Peers’
MedReleaf (MEDFF) has all of its facilities and expansion projects based in Ontario, Canada (HMMJ).
Unlike Canopy, Aurora Cannabis Will Build Capacity outside Canada
Aurora Cannabis (ACB) (ACBFF), another licensed cannabis producer, is also doing its part to expand its capacity.
Factors Expected to Influence the Provinces’ Supplier Decisions
Ahead of the legalization of recreational cannabis, companies are ramping up their production capacities.
How Cannabis Companies Are Rushing to Expand Operations
In anticipation of recreational cannabis’s legalization at the federal level in Canada, provinces have been doing their best to prepare.
Analysts’ Revenue Estimate Revisions for Cannabis Stocks in March
Cannabis producers’ (HMLSF) sales are expected to rise on expectations of their capturing the recreational cannabis market.
Shoppers Drug Mart Makes Supply Deal with Aurora Cannabis
Last week, Shoppers Drug Mart entered a supply agreement with Aurora Cannabis (ACB)(ACBFF) for medical cannabis.
Why Cannabis Stock Cronos Group Surged 11% Yesterday
On February 26, cannabis company (HMMJ) Cronos Group (MJN)(PRMCF) surged almost 10.8%.
Manitoba and Quebec Announced Cannabis Retailers and Suppliers
Last week, the province of Manitoba announced four private consortiums and companies to retail marijuana in the province.
A Look at 2 New Marijuana ETFs that Debuted Last Week
While marijuana stocks (MJX) ended in the negative territory week-over-week last week, two new marijuana sector-specific ETFs debuted.
Key Developments in the Cannabis Sector Last Week
The week ending February 16 wasn’t so positive for marijuana stocks even though the broader market indexes ended in the positive territory.
How Canopy Growth’s Margins Looked in 3Q18
During 3Q18, Canopy Growth reported a non-GAAP (generally accepted accounting principles) gross margin of 58% of sales.
What Were Canopy Growth’s 3Q18 Sales Drivers?
Sales volume, mix, and selling prices are key drivers for Canopy Growth’s (WEED) sales as well as for companies (HMLSF) such as Aphria (APHQF), Aurora Cannabis (ACBFF), and MedReleaf (MEDFF).
What Analysts Estimate for Cannabis Companies’ Earnings Margins
Let’s now look at how capacity expansion could translate into cannabis companies’ margins.
MedReleaf’s Analyst Ratings and Price Target
The current consensus mean rating for MedReleaf stood at 1.6 with an overall “buy” recommendation on the stock for the next-12-month period.
Aurora Cannabis’s Price Target and Analyst Ratings
The current consensus mean price target on Aphria stood at 9.00 Canadian dollars, which is significantly below the company’s price of 11.50 Canadian dollars on February 6.
Aurora Cannabis: Does Investment in Liquor Stores Fit Framework?
With the opportunity for private players to run cannabis stores in British Columbia and Alberta, the partnership of Aurora Cannabis and Liquor Stores NA could come at an opportune time.
Aurora Cannabis Announced Another Investment on February 5
On February 5, 2018, Aurora Cannabis (ACB) (ACBFF) issued a press release that gave details on its latest investment in Liquor Stores NA (LIQ).
How Analysts’ Estimates for Cannabis Companies Have Evolved
Earlier, we were left with the question of whether the valuations of cannabis stocks had been stretched. To answer that question, we’ll have to look at what was priced in to their valuation multiples.
Why Cannabis Stocks Fell in the Week Ended February 2
The week ended February 2, 2018, was negative not only for cannabis stocks but also for the broader market.